Jack Dabrowski
Advisor
CRHI
Jack Dabrowski is a healthcare product strategy and commercialization executive with deep experience guiding innovative technologies and devices from concept to scalable success. His background spans biotech R&D, medical device development, digital health navigation, and care delivery innovation – equipping him to help early-stage companies align products with market needs and accelerate adoption.
He specializes in strategies and frameworks that reduce commercialization risk and bring clarity to product development. His focus includes product refinement, market access planning, go-to-market execution, cross-functional coordination, and strategic brand positioning – ensuring compelling value propositions and efficient pathways to market.
Jack brings a wealth of development experience across biotech and healthcare from organizations including Monsanto, Sigma Aldrich, Allied Healthcare Products, and BJC HealthCare, supporting the commercialization and market access strategies of a broad range of medical, life sciences, and digital health navigation innovations across U.S. and international markets.
With a foundation in science and a track record of operational success, Jack brings a unique lens to evaluating and advancing innovations across complex healthcare environments.